Apis India Ltd.
Apis India Ltd. (APIS.BO) Stock Competitors & Peer Comparison
See (APIS.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Food Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| APIS.BO | ₹62.00 | +7.73% | 332.9M | -2.13 | -₹28.30 | N/A |
| DODLA.BO | ₹995.25 | +2.49% | 61B | 31.08 | ₹32.53 | +0.20% |
| DODLA.NS | ₹1,002.60 | +3.24% | 61B | 31.06 | ₹32.53 | +0.20% |
| EMPIND.BO | ₹860.35 | +3.33% | 5.2B | 13.94 | ₹61.70 | +2.91% |
| PROV.NS | ₹1,160.00 | -2.19% | 4B | 43.77 | ₹26.50 | N/A |
| SVJ.BO | ₹483.90 | +2.30% | 2.7B | 930.38 | ₹0.52 | N/A |
| AVEER.BO | ₹511.65 | -1.70% | 2.2B | 55.25 | ₹9.26 | +0.05% |
| MADHUSUDAN.NS | ₹143.95 | +5.07% | 2.1B | 13.17 | ₹10.93 | N/A |
| NEAGI.BO | ₹3,156.70 | +1.83% | 2B | 7.36 | ₹428.80 | +0.95% |
| FRSHTRP.BO | ₹134.90 | +0.00% | 1.5B | 129.09 | ₹1.05 | N/A |
Stock Comparison
APIS.BO vs DODLA.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, DODLA.BO has a market cap of 61B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while DODLA.BO trades at ₹995.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas DODLA.BO's P/E ratio is 31.08. In terms of profitability, APIS.BO's ROE is +0.13%, compared to DODLA.BO's ROE of +0.19%. Regarding short-term risk, APIS.BO is more volatile compared to DODLA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check DODLA.BO's competition here
APIS.BO vs DODLA.NS Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, DODLA.NS has a market cap of 61B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while DODLA.NS trades at ₹1,002.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas DODLA.NS's P/E ratio is 31.06. In terms of profitability, APIS.BO's ROE is +0.13%, compared to DODLA.NS's ROE of +0.19%. Regarding short-term risk, APIS.BO is less volatile compared to DODLA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check DODLA.NS's competition here
APIS.BO vs EMPIND.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, EMPIND.BO has a market cap of 5.2B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while EMPIND.BO trades at ₹860.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas EMPIND.BO's P/E ratio is 13.94. In terms of profitability, APIS.BO's ROE is +0.13%, compared to EMPIND.BO's ROE of +0.12%. Regarding short-term risk, APIS.BO is less volatile compared to EMPIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check EMPIND.BO's competition here
APIS.BO vs PROV.NS Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, PROV.NS has a market cap of 4B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while PROV.NS trades at ₹1,160.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas PROV.NS's P/E ratio is 43.77. In terms of profitability, APIS.BO's ROE is +0.13%, compared to PROV.NS's ROE of N/A. Regarding short-term risk, APIS.BO is less volatile compared to PROV.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check PROV.NS's competition here
APIS.BO vs SVJ.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, SVJ.BO has a market cap of 2.7B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while SVJ.BO trades at ₹483.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas SVJ.BO's P/E ratio is 930.38. In terms of profitability, APIS.BO's ROE is +0.13%, compared to SVJ.BO's ROE of +0.02%. Regarding short-term risk, APIS.BO is more volatile compared to SVJ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check SVJ.BO's competition here
APIS.BO vs AVEER.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, AVEER.BO has a market cap of 2.2B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while AVEER.BO trades at ₹511.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas AVEER.BO's P/E ratio is 55.25. In terms of profitability, APIS.BO's ROE is +0.13%, compared to AVEER.BO's ROE of +0.12%. Regarding short-term risk, APIS.BO is more volatile compared to AVEER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check AVEER.BO's competition here
APIS.BO vs MADHUSUDAN.NS Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, MADHUSUDAN.NS has a market cap of 2.1B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while MADHUSUDAN.NS trades at ₹143.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas MADHUSUDAN.NS's P/E ratio is 13.17. In terms of profitability, APIS.BO's ROE is +0.13%, compared to MADHUSUDAN.NS's ROE of N/A. Regarding short-term risk, APIS.BO is less volatile compared to MADHUSUDAN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check MADHUSUDAN.NS's competition here
APIS.BO vs NEAGI.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, NEAGI.BO has a market cap of 2B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while NEAGI.BO trades at ₹3,156.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas NEAGI.BO's P/E ratio is 7.36. In terms of profitability, APIS.BO's ROE is +0.13%, compared to NEAGI.BO's ROE of +0.09%. Regarding short-term risk, APIS.BO is less volatile compared to NEAGI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check NEAGI.BO's competition here
APIS.BO vs FRSHTRP.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, FRSHTRP.BO has a market cap of 1.5B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while FRSHTRP.BO trades at ₹134.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas FRSHTRP.BO's P/E ratio is 129.09. In terms of profitability, APIS.BO's ROE is +0.13%, compared to FRSHTRP.BO's ROE of +0.53%. Regarding short-term risk, APIS.BO is less volatile compared to FRSHTRP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check FRSHTRP.BO's competition here
APIS.BO vs PURETROP.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, PURETROP.BO has a market cap of 1.5B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while PURETROP.BO trades at ₹184.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas PURETROP.BO's P/E ratio is 66.18. In terms of profitability, APIS.BO's ROE is +0.13%, compared to PURETROP.BO's ROE of +0.53%. Regarding short-term risk, APIS.BO is more volatile compared to PURETROP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check PURETROP.BO's competition here
APIS.BO vs BENGALT.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, BENGALT.BO has a market cap of 1.3B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while BENGALT.BO trades at ₹145.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas BENGALT.BO's P/E ratio is 12.98. In terms of profitability, APIS.BO's ROE is +0.13%, compared to BENGALT.BO's ROE of +0.05%. Regarding short-term risk, APIS.BO is more volatile compared to BENGALT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check BENGALT.BO's competition here
APIS.BO vs ESSENTIA.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, ESSENTIA.BO has a market cap of 1.3B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while ESSENTIA.BO trades at ₹1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas ESSENTIA.BO's P/E ratio is 40.33. In terms of profitability, APIS.BO's ROE is +0.13%, compared to ESSENTIA.BO's ROE of +0.02%. Regarding short-term risk, APIS.BO is less volatile compared to ESSENTIA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check ESSENTIA.BO's competition here
APIS.BO vs HALDER.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, HALDER.BO has a market cap of 1.1B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while HALDER.BO trades at ₹257.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas HALDER.BO's P/E ratio is 3215.00. In terms of profitability, APIS.BO's ROE is +0.13%, compared to HALDER.BO's ROE of +0.03%. Regarding short-term risk, APIS.BO is more volatile compared to HALDER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check HALDER.BO's competition here
APIS.BO vs JAMESWARREN.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, JAMESWARREN.BO has a market cap of 1B. Regarding current trading prices, APIS.BO is priced at ₹62.00, while JAMESWARREN.BO trades at ₹271.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas JAMESWARREN.BO's P/E ratio is 1.29. In terms of profitability, APIS.BO's ROE is +0.13%, compared to JAMESWARREN.BO's ROE of +0.42%. Regarding short-term risk, APIS.BO is less volatile compared to JAMESWARREN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check JAMESWARREN.BO's competition here
APIS.BO vs ANIKINDS.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, ANIKINDS.BO has a market cap of 998.6M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while ANIKINDS.BO trades at ₹33.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas ANIKINDS.BO's P/E ratio is 58.98. In terms of profitability, APIS.BO's ROE is +0.13%, compared to ANIKINDS.BO's ROE of +0.00%. Regarding short-term risk, APIS.BO is less volatile compared to ANIKINDS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check ANIKINDS.BO's competition here
APIS.BO vs ANIKINDS.NS Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, ANIKINDS.NS has a market cap of 981.1M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while ANIKINDS.NS trades at ₹34.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas ANIKINDS.NS's P/E ratio is 57.95. In terms of profitability, APIS.BO's ROE is +0.13%, compared to ANIKINDS.NS's ROE of +0.00%. Regarding short-term risk, APIS.BO is less volatile compared to ANIKINDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check ANIKINDS.NS's competition here
APIS.BO vs MRP.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, MRP.BO has a market cap of 961.4M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while MRP.BO trades at ₹86.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas MRP.BO's P/E ratio is 16.49. In terms of profitability, APIS.BO's ROE is +0.13%, compared to MRP.BO's ROE of +0.20%. Regarding short-term risk, APIS.BO is less volatile compared to MRP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check MRP.BO's competition here
APIS.BO vs LYKISLTD.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, LYKISLTD.BO has a market cap of 913M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while LYKISLTD.BO trades at ₹45.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas LYKISLTD.BO's P/E ratio is 23.80. In terms of profitability, APIS.BO's ROE is +0.13%, compared to LYKISLTD.BO's ROE of +0.11%. Regarding short-term risk, APIS.BO is more volatile compared to LYKISLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check LYKISLTD.BO's competition here
APIS.BO vs TIGLOB.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, TIGLOB.BO has a market cap of 856.2M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while TIGLOB.BO trades at ₹168.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas TIGLOB.BO's P/E ratio is 11.72. In terms of profitability, APIS.BO's ROE is +0.13%, compared to TIGLOB.BO's ROE of +0.08%. Regarding short-term risk, APIS.BO is less volatile compared to TIGLOB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check TIGLOB.BO's competition here
APIS.BO vs MODAIRY.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, MODAIRY.BO has a market cap of 850.6M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while MODAIRY.BO trades at ₹32.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas MODAIRY.BO's P/E ratio is 3.66. In terms of profitability, APIS.BO's ROE is +0.13%, compared to MODAIRY.BO's ROE of +1.28%. Regarding short-term risk, APIS.BO is less volatile compared to MODAIRY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check MODAIRY.BO's competition here
APIS.BO vs TANVI.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, TANVI.BO has a market cap of 789M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while TANVI.BO trades at ₹61.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas TANVI.BO's P/E ratio is 157.69. In terms of profitability, APIS.BO's ROE is +0.13%, compared to TANVI.BO's ROE of +0.00%. Regarding short-term risk, APIS.BO is more volatile compared to TANVI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check TANVI.BO's competition here
APIS.BO vs IBINFO.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, IBINFO.BO has a market cap of 776.4M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while IBINFO.BO trades at ₹606.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas IBINFO.BO's P/E ratio is 48.77. In terms of profitability, APIS.BO's ROE is +0.13%, compared to IBINFO.BO's ROE of +0.61%. Regarding short-term risk, APIS.BO is more volatile compared to IBINFO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check IBINFO.BO's competition here
APIS.BO vs TERAI.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, TERAI.BO has a market cap of 729.2M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while TERAI.BO trades at ₹106.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas TERAI.BO's P/E ratio is -11.42. In terms of profitability, APIS.BO's ROE is +0.13%, compared to TERAI.BO's ROE of -0.00%. Regarding short-term risk, APIS.BO is less volatile compared to TERAI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check TERAI.BO's competition here
APIS.BO vs FCONSUMER.NS Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, FCONSUMER.NS has a market cap of 619.1M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while FCONSUMER.NS trades at ₹0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas FCONSUMER.NS's P/E ratio is -1.24. In terms of profitability, APIS.BO's ROE is +0.13%, compared to FCONSUMER.NS's ROE of +0.16%. Regarding short-term risk, APIS.BO is less volatile compared to FCONSUMER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check FCONSUMER.NS's competition here
APIS.BO vs ANVRDHI.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, ANVRDHI.BO has a market cap of 446.8M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while ANVRDHI.BO trades at ₹9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas ANVRDHI.BO's P/E ratio is 97.50. In terms of profitability, APIS.BO's ROE is +0.13%, compared to ANVRDHI.BO's ROE of +0.03%. Regarding short-term risk, APIS.BO is more volatile compared to ANVRDHI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check ANVRDHI.BO's competition here
APIS.BO vs UNIQUEO.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, UNIQUEO.BO has a market cap of 440.4M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while UNIQUEO.BO trades at ₹74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas UNIQUEO.BO's P/E ratio is 6.68. In terms of profitability, APIS.BO's ROE is +0.13%, compared to UNIQUEO.BO's ROE of +0.20%. Regarding short-term risk, APIS.BO is less volatile compared to UNIQUEO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check UNIQUEO.BO's competition here
APIS.BO vs SWOEF.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, SWOEF.BO has a market cap of 424.8M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while SWOEF.BO trades at ₹13.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas SWOEF.BO's P/E ratio is N/A. In terms of profitability, APIS.BO's ROE is +0.13%, compared to SWOEF.BO's ROE of +0.43%. Regarding short-term risk, APIS.BO is more volatile compared to SWOEF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check SWOEF.BO's competition here
APIS.BO vs CONTILI.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, CONTILI.BO has a market cap of 423.5M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while CONTILI.BO trades at ₹27.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas CONTILI.BO's P/E ratio is 18.62. In terms of profitability, APIS.BO's ROE is +0.13%, compared to CONTILI.BO's ROE of +0.20%. Regarding short-term risk, APIS.BO is less volatile compared to CONTILI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check CONTILI.BO's competition here
APIS.BO vs JFL.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, JFL.BO has a market cap of 418.3M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while JFL.BO trades at ₹27.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas JFL.BO's P/E ratio is 5.61. In terms of profitability, APIS.BO's ROE is +0.13%, compared to JFL.BO's ROE of +0.17%. Regarding short-term risk, APIS.BO is less volatile compared to JFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check JFL.BO's competition here
APIS.BO vs SPECFOOD.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, SPECFOOD.BO has a market cap of 298.7M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while SPECFOOD.BO trades at ₹12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas SPECFOOD.BO's P/E ratio is -1232.00. In terms of profitability, APIS.BO's ROE is +0.13%, compared to SPECFOOD.BO's ROE of -0.01%. Regarding short-term risk, APIS.BO is less volatile compared to SPECFOOD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check SPECFOOD.BO's competition here
APIS.BO vs CHORDIA.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, CHORDIA.BO has a market cap of 276M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while CHORDIA.BO trades at ₹68.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas CHORDIA.BO's P/E ratio is 43.36. In terms of profitability, APIS.BO's ROE is +0.13%, compared to CHORDIA.BO's ROE of +0.04%. Regarding short-term risk, APIS.BO is less volatile compared to CHORDIA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check CHORDIA.BO's competition here
APIS.BO vs KMGMILK.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, KMGMILK.BO has a market cap of 244.3M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while KMGMILK.BO trades at ₹46.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas KMGMILK.BO's P/E ratio is -191.92. In terms of profitability, APIS.BO's ROE is +0.13%, compared to KMGMILK.BO's ROE of -0.23%. Regarding short-term risk, APIS.BO is more volatile compared to KMGMILK.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check KMGMILK.BO's competition here
APIS.BO vs WORL.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, WORL.BO has a market cap of 235.6M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while WORL.BO trades at ₹7.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas WORL.BO's P/E ratio is -1.40. In terms of profitability, APIS.BO's ROE is +0.13%, compared to WORL.BO's ROE of +0.51%. Regarding short-term risk, APIS.BO is less volatile compared to WORL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check WORL.BO's competition here
APIS.BO vs SCAGRO.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, SCAGRO.BO has a market cap of 190.2M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while SCAGRO.BO trades at ₹31.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas SCAGRO.BO's P/E ratio is 209.07. In terms of profitability, APIS.BO's ROE is +0.13%, compared to SCAGRO.BO's ROE of +0.80%. Regarding short-term risk, APIS.BO is less volatile compared to SCAGRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check SCAGRO.BO's competition here
APIS.BO vs JETMALL.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, JETMALL.BO has a market cap of 188M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while JETMALL.BO trades at ₹31.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas JETMALL.BO's P/E ratio is -18.03. In terms of profitability, APIS.BO's ROE is +0.13%, compared to JETMALL.BO's ROE of -0.08%. Regarding short-term risk, APIS.BO is more volatile compared to JETMALL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check JETMALL.BO's competition here
APIS.BO vs NCCBLUE.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, NCCBLUE.BO has a market cap of 187.8M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while NCCBLUE.BO trades at ₹24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas NCCBLUE.BO's P/E ratio is -17.06. In terms of profitability, APIS.BO's ROE is +0.13%, compared to NCCBLUE.BO's ROE of +0.22%. Regarding short-term risk, APIS.BO is more volatile compared to NCCBLUE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check NCCBLUE.BO's competition here
APIS.BO vs NMSRESRC.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, NMSRESRC.BO has a market cap of 180M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while NMSRESRC.BO trades at ₹59.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas NMSRESRC.BO's P/E ratio is 25.92. In terms of profitability, APIS.BO's ROE is +0.13%, compared to NMSRESRC.BO's ROE of +0.28%. Regarding short-term risk, APIS.BO is less volatile compared to NMSRESRC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check NMSRESRC.BO's competition here
APIS.BO vs SHANTHALA.NS Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, SHANTHALA.NS has a market cap of 176.8M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while SHANTHALA.NS trades at ₹26.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas SHANTHALA.NS's P/E ratio is 13.89. In terms of profitability, APIS.BO's ROE is +0.13%, compared to SHANTHALA.NS's ROE of N/A. Regarding short-term risk, APIS.BO is more volatile compared to SHANTHALA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check SHANTHALA.NS's competition here
APIS.BO vs VIKASWSP.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, VIKASWSP.BO has a market cap of 175.8M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while VIKASWSP.BO trades at ₹0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas VIKASWSP.BO's P/E ratio is -0.66. In terms of profitability, APIS.BO's ROE is +0.13%, compared to VIKASWSP.BO's ROE of -0.03%. Regarding short-term risk, APIS.BO is less volatile compared to VIKASWSP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check VIKASWSP.BO's competition here
APIS.BO vs HEALTHYLIFE.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, HEALTHYLIFE.BO has a market cap of 166.9M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while HEALTHYLIFE.BO trades at ₹6.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas HEALTHYLIFE.BO's P/E ratio is 13.80. In terms of profitability, APIS.BO's ROE is +0.13%, compared to HEALTHYLIFE.BO's ROE of +0.11%. Regarding short-term risk, APIS.BO is more volatile compared to HEALTHYLIFE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check HEALTHYLIFE.BO's competition here
APIS.BO vs ANSINDUS.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, ANSINDUS.BO has a market cap of 165.1M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while ANSINDUS.BO trades at ₹17.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas ANSINDUS.BO's P/E ratio is 9.86. In terms of profitability, APIS.BO's ROE is +0.13%, compared to ANSINDUS.BO's ROE of -0.17%. Regarding short-term risk, APIS.BO is more volatile compared to ANSINDUS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check ANSINDUS.BO's competition here
APIS.BO vs UNRYLMA.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, UNRYLMA.BO has a market cap of 106.3M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while UNRYLMA.BO trades at ₹16.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas UNRYLMA.BO's P/E ratio is 8.04. In terms of profitability, APIS.BO's ROE is +0.13%, compared to UNRYLMA.BO's ROE of +4.58%. Regarding short-term risk, APIS.BO is less volatile compared to UNRYLMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check UNRYLMA.BO's competition here
APIS.BO vs TDSL.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, TDSL.BO has a market cap of 103.6M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while TDSL.BO trades at ₹5.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas TDSL.BO's P/E ratio is -1.40. In terms of profitability, APIS.BO's ROE is +0.13%, compared to TDSL.BO's ROE of +0.23%. Regarding short-term risk, APIS.BO is less volatile compared to TDSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check TDSL.BO's competition here
APIS.BO vs UNJHAFOR.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, UNJHAFOR.BO has a market cap of 87.4M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while UNJHAFOR.BO trades at ₹19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas UNJHAFOR.BO's P/E ratio is 8.37. In terms of profitability, APIS.BO's ROE is +0.13%, compared to UNJHAFOR.BO's ROE of +0.30%. Regarding short-term risk, APIS.BO is less volatile compared to UNJHAFOR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check UNJHAFOR.BO's competition here
APIS.BO vs NEWTRAC.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, NEWTRAC.BO has a market cap of 77.4M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while NEWTRAC.BO trades at ₹4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas NEWTRAC.BO's P/E ratio is -0.09. In terms of profitability, APIS.BO's ROE is +0.13%, compared to NEWTRAC.BO's ROE of N/A. Regarding short-term risk, APIS.BO is less volatile compared to NEWTRAC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check NEWTRAC.BO's competition here
APIS.BO vs OLYOI.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, OLYOI.BO has a market cap of 68.2M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while OLYOI.BO trades at ₹23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas OLYOI.BO's P/E ratio is -64.59. In terms of profitability, APIS.BO's ROE is +0.13%, compared to OLYOI.BO's ROE of +0.01%. Regarding short-term risk, APIS.BO is more volatile compared to OLYOI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check OLYOI.BO's competition here
APIS.BO vs SHAQUAK.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, SHAQUAK.BO has a market cap of 42.6M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while SHAQUAK.BO trades at ₹1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas SHAQUAK.BO's P/E ratio is -40.67. In terms of profitability, APIS.BO's ROE is +0.13%, compared to SHAQUAK.BO's ROE of -0.01%. Regarding short-term risk, APIS.BO is less volatile compared to SHAQUAK.BO. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check SHAQUAK.BO's competition here
APIS.BO vs THAKKERS.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, THAKKERS.BO has a market cap of 33.3M. Regarding current trading prices, APIS.BO is priced at ₹62.00, while THAKKERS.BO trades at ₹21.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas THAKKERS.BO's P/E ratio is N/A. In terms of profitability, APIS.BO's ROE is +0.13%, compared to THAKKERS.BO's ROE of N/A. Regarding short-term risk, APIS.BO is more volatile compared to THAKKERS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check THAKKERS.BO's competition here
APIS.BO vs HATSUN-RE.NS Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, HATSUN-RE.NS has a market cap of 0. Regarding current trading prices, APIS.BO is priced at ₹62.00, while HATSUN-RE.NS trades at ₹480.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas HATSUN-RE.NS's P/E ratio is N/A. In terms of profitability, APIS.BO's ROE is +0.13%, compared to HATSUN-RE.NS's ROE of N/A. Regarding short-term risk, APIS.BO is less volatile compared to HATSUN-RE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for APIS.BO.Check HATSUN-RE.NS's competition here
APIS.BO vs EVERTEX.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, EVERTEX.BO has a market cap of 0. Regarding current trading prices, APIS.BO is priced at ₹62.00, while EVERTEX.BO trades at ₹64.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas EVERTEX.BO's P/E ratio is N/A. In terms of profitability, APIS.BO's ROE is +0.13%, compared to EVERTEX.BO's ROE of N/A. Regarding short-term risk, APIS.BO is more volatile compared to EVERTEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check EVERTEX.BO's competition here
APIS.BO vs ICLORGANIC.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, ICLORGANIC.BO has a market cap of 0. Regarding current trading prices, APIS.BO is priced at ₹62.00, while ICLORGANIC.BO trades at ₹39.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas ICLORGANIC.BO's P/E ratio is N/A. In terms of profitability, APIS.BO's ROE is +0.13%, compared to ICLORGANIC.BO's ROE of N/A. Regarding short-term risk, APIS.BO is more volatile compared to ICLORGANIC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check ICLORGANIC.BO's competition here
APIS.BO vs TINNATFL.BO Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, TINNATFL.BO has a market cap of 0. Regarding current trading prices, APIS.BO is priced at ₹62.00, while TINNATFL.BO trades at ₹361.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas TINNATFL.BO's P/E ratio is N/A. In terms of profitability, APIS.BO's ROE is +0.13%, compared to TINNATFL.BO's ROE of +0.00%. Regarding short-term risk, APIS.BO is more volatile compared to TINNATFL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check TINNATFL.BO's competition here
APIS.BO vs MVKAGRO-ST.NS Comparison April 2026
APIS.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APIS.BO stands at 332.9M. In comparison, MVKAGRO-ST.NS has a market cap of 0. Regarding current trading prices, APIS.BO is priced at ₹62.00, while MVKAGRO-ST.NS trades at ₹576.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APIS.BO currently has a P/E ratio of -2.13, whereas MVKAGRO-ST.NS's P/E ratio is N/A. In terms of profitability, APIS.BO's ROE is +0.13%, compared to MVKAGRO-ST.NS's ROE of N/A. Regarding short-term risk, APIS.BO is more volatile compared to MVKAGRO-ST.NS. This indicates potentially higher risk in terms of short-term price fluctuations for APIS.BO.Check MVKAGRO-ST.NS's competition here